Berberine-induced growth inhibition of epithelial ovarian carcinoma cell lines

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 3, 2012, Pages 535-540

  Park, Kyoung Sik ^a   Kim, Jong Bin ^b   Lee, Sun Joo ^a   Bae, Jaeman ^a  

^a Konkuk University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Anticancer medication; Berberine; Ovarian cancer; OVCAR 3; SKOV 3

Indexed keywords

BERBERINE; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN P27;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; OVARY CARCINOMA; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BERBERINE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNOBLOTTING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 84860880917     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01743.x     Document Type: Article

References (18)

1. Arayne MS, Sultana N, Bahadur SS. The berberis story: Berberis vulgaris in therapeutics. Pak J Pharm Sci 2007; 20: 83-92.
2. Lee S, Lim HJ, Park HY, Lee KS, Park JH, Jang Y. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo. Berberine improves neointima formation in a rat model. Atherosclerosis 2006; 186: 29-37.
3. Imanshahidi M, Hosseinzadeh H. Pharmacological and therapeutic effects of berberis vulgaris and its active constituent, berberine. Phytother Res 2008; 22: 999-1012.
4. Abidi P, Zhou Y, Jiang JD, Liu J. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptormRNAby herbal medicine berberine. Arterioscler Thromb Vasc Biol 2005; 25: 2170-2176. (Pubitemid 41416317)
5. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta pharmacol Sin 2004; 25: 496-502.
6. Inoue K, Kulsum U, Chowdhury SA et al. Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Res 2005; 25: 4053-4059. (Pubitemid 41665185)
7. Peng PL, Hsieh YS, Wang CJ, Hsu JL, Chou FP. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol 2006; 214: 8-15.
8. Jantova S, Letasiova S, Brezova V, Cipak L, Labaj J. Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells. J Photochem Photobiol B 2006; 85: 163-176. (Pubitemid 44567375)
9. Katiyar SK, Meeran SM, Katiyar N, Akhtar S. p53 cooperates berberine-induced growth inhibition and apoptosis of nonsmall cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Mol Carcinog 2009; 48: 24-37.
10. Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase- 3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006; 5: 296-308.
11. Lin CC, Kao ST, Chen GW, Ho HC, Chung JG. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res 2006; 26: 227-242.
12. Kim JB, Yu JH, Ko E et al. The alkaloid berberine inhibits the growth of anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine 2010; 17: 436-440.
13. Ozols RF. Treatment goals in ovarian cancer. Int J Gynecol Cancer 2005; 15 (Suppl 1): 3-11. (Pubitemid 40696471)
14. Kang MR, Chung IK. Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine. Mol Pharmacol 2002; 61: 879-884. (Pubitemid 34273168)
15. Jantova S, Cipak L, Cernakova M, Kost'alova D. Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol 2003; 55: 1143-1149. (Pubitemid 36998656)
16. Lin CC, Lin SY, Chung JG, Lin JP, Chen GW, Kao ST. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/Mphase of the cell cycle. Anticancer Res 2006; 26: 1097-1104.
17. Letasiova S, Jantova S, Miko M, Ovadekova R, Horvathova M. Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells. J Pharm Pharmacol 2006; 58: 263-270. (Pubitemid 43164284)
18. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-1420. (Pubitemid 24273007)